Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7393-7398

  Duffner, Ulrich A ^a,b   Maeda, Yoshinobu ^a   Cooke, Kenneth R ^a   Reddy, Pavan ^a   Ordemann, Rainer ^a   Liu, Chen ^c   Ferrara, James L M ^a   Teshima, Takanori ^a,d,e  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d OKAYAMA UNIVERSITY   (Japan)

^e OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; COLON; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; LIVER; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 2942627451     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7393     Document Type: Article

References (33)

1. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412.
2. Inaba, K., and R. M. Steinman. 1984. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J. Exp. Med. 160:1717.
3. Boog, C. J., W. M. Kast, H. T. Timmers, J. Boes, L. P. de Waal, and C. J. Melief. 1985. Abolition of specific immune response defect by immunization with dendritic cells. Nature 318:59.
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
5. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
6. Eynon, E. E., and D. C. Parker. 1993. Parameters of tolerance induction by antigen targeted to B lymphocytes. J. Immunol. 151:2958.
7. Morris, S. C., A. Lees, and F. D. Finkelman. 1994. In vivo activation of naive T cells by antigen-presenting B cells. J. Immunol. 152:3777.
8. + T cell priming in vivo. J. Immunol. 162:5695.
9. Hill, G. R., and J. L. Ferrara. 2000. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95:2754.
10. + cells in class I different hosts. J. Exp. Med. 167:556.
11. Korngold, R., and J. Sprent. 1990. T cell subsets in graft-vs.-host disease. In Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment. S. J. Burakoff, H. J. Deeg, J. Ferrara, and K. Atkinson, eds. Marcel Dekker, New York, pp. 31-50.
12. Teshima, T., R. Ordemann, P. Reddy, S. Gagin, C. Liu, K. R. Cooke, and J. L. Ferrara. 2002. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 8:575.
13. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
14. + dendritic cells and reduces experimental acute graft-versus-host disease. Blood 99:1825.
15. Wall, D. A., S. D. Hamberg, D. S. Reynolds, S. J. Burakoff, A. K. Abbas, and J. L. M. Ferrara. 1988. Immunodeficiency in graft-versus-host reaction. I. Mechanism of immune suppression. J. Immunol. 140:2970.
16. Cooke, K. R., L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte, J. M. Crawford, and J. L. M. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin. Blood 88:3230.
17. Baker, M. B., R. L. Riley, E. R. Podack, and R. B. Levy. 1997. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proc. Natl. Acad. Sci. USA 94:1366.
18. Hakim, F. T., and C. L. Mackall. 1997. The immune system: effector and target of graft-versus-host disease. In Graft-vs-Host Disease, 2nd Ed. J. L. M. Ferrara, H. J. Deeg, and S. J. Burakoff, eds. Marcel Dekker, New York, pp. 257-289.
19. Cooke, K. R., W. Krenger, G. Hill, T. R. Martin, L. Kobzik, J. Brewer, R. Simmons, J. M. Crawford, M. R. Van den Brink, and J. L. Ferrara. 1998. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92:2571.
20. Hill, G. R., et al. 1998. Interleukin-II promotes T-cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Clin. Invest. 102:115.
21. Teshima, T., N. Mach, G. R. Hill, L. Pan, S. Gillessen, G. Dranoff, and J. L. Ferrara. 2001. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Res. 61:162.
22. Eggert, A. A., M. W. Schreurs, O. C. Boerman, W. J. Oyen, A. J. de Boer, C. J. Punt, C. G. Figdor, and G. J. Adema. 1999. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59:3340.
23. Mitchison, N. A. 1968. The dosage requirements for immunological paralysis by soluble proteins. Immunology 15:509.
24. Lassila, O., O. Vainio, and P. Matzinger. 1988. Can B cells turn on virgin T cells? Nature 334:253.
25. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenfing cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131.
26. Sprent, J., M. Schaefer, D. Lo, and R. Korngold. 1986. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J. Exp. Med. 163:998.
27. Krasinskas, A. M., S. D. Eiref, A. D. McLean, D. Kreisel, A. E. Gelman, S. H. Popma, J. S. Moore, and B. R. Rosengard. 2000. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection. Transplantation 70:514.
28. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand treated mice: multiple dendritic cell subpopulation identified. J. Exp. Med. 184:1953.
29. + T cells to elicit hepatic graft-versus-host disease. J. Immunol. 169:7111.
30. McCarthy, P. L., S. Abhyankar, S. Neben, G. Newman, C. Sieff, R. C. Thompson, S. J. Burakoff, and J. L. M. Ferrara. 1991. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 78:1915.
31. Hattori, K., T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura. 1998. Differential effects of anti-Fas ligand and anti-tumor necrosis factor-α antibodies on acute graft-versus-host disease pathologies. Blood 91:4051.
32. + T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109:1335.
33. Mapara, M. Y., Y.-M. Kim, S.-P. Wang, R. Bronson, D. H. Sachs, and M. Sykes. 2002. Donor lymphocyte infusion mediates superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100:1903.